Clara Maass Medical Center is the only hospital in New Jersey to offer a revolutionary eye implant, the Argus® II Retinal Prosthesis System.
Renowned vitreoretinal surgeon, Paul Hahn, MD, PhD, of NJRetina is performing this cutting-edge implant procedure to partially restore vision for patients who have lost their sight due to retinitis pigmentosa.
Most insurances are accepted.
If you have late-stage retinitis pigmentosa (RP), you may be a candidate for the Argus® II Retinal Prosthesis System, a retinal implant that can provide partial sight for individuals with the disease.
The Argus II Retinal Prosthesis System is FDA-approved and intended for use in patients with severe to profound retinitis pigmentosa who meet the following criteria:
- Retinitis pigmentosa
- Bare light or no light perception in both eyes due to retinitis pigmentosa
- Adults, age 25 years or older
- Previous history of useful form vision
- Wiling and able to receive the recommended post-implant clinical follow-up, device fitting, and low-vision rehabilitation
How it Works
The Argus® II Retinal Prosthesis System consists of two primary pieces, glasses and a retinal implant, which work together to induce visual perception:
- The glasses are equipped with a video camera that captures images and converts them into a series of small electrical pulses.
- These electrical pulses are wirelessly transmitted to the retinal implant, which then stimulates the retina’s remaining cells, resulting in a corresponding perception of patterns of light in the brain.
The retinal implant is programmed post-surgery and is intended for only one eye, typically the worse-seeing eye.
Under the leadership of retina specialist Paul Hahn, MD, PhD, and NJRetina, the comprehensive ophthalmic program at Clara Maass Medical Center is the only one of its kind in New Jersey to perform retinal implants.
About Dr. Paul Hahn
Dr. Paul Hahn, a New York City native and pioneering eye surgeon, returned to the northeast in 2016 to join the medical staff at Clara Maass Medical Center and the advanced eye care team at NJRetina.
Dr. Hahn attended Harvard University where he was awarded the Detur Prize for Academic Achievement of the Highest Distinction – awarded to top 5-10% of first- year students based on academic merit—the John Harvard Scholarship for academic excellence. He then graduated magna cum laude from Harvard University with a degree in Biochemical Sciences. He then followed in the footsteps of his father and grandfather, who were both ophthalmologists, and completed his medical education at the University of Pennsylvania School of Medicine. He was sponsored by the National Institute of Health for completion of his MD, along with a PhD degree in molecular pharmacology investigating novel treatment pathways for dry age-related macular degeneration. Dr. Hahn then completed his ophthalmology residency at the Scheie Eye Institute at the University of Pennsylvania, followed by a two-year fellowship in vitreoretinal diseases and surgery at Duke University.
After he completed his fellowship, Dr. Hahn remained at Duke University as an Assistant Professor of Ophthalmology at Duke’s medical school for nearly four years, where he gained experience in managing the full range of eye conditions, including the most complex of complications. Read more about Dr. Hahn
For inquiries or to refer a patient, contact the NJRetina office at (201) 808-5565.